Type 2 Diabetes

Disease State Hub

Podcasts

NUTRITION411: THE PODCAST, EP. 48

NUTRITION411: THE PODCAST, EP. 48

Interpreting CGM Data For Improved Dietary Planning, Pt. 2

02/21/2015

Lisa Jones, MA, RDN, LDN, FAND

In part two of this four-part series, Lisa Jones, MA, RDN, LDN, FAND, interviews Grace A. Derocha, MBA, RD, CDCES, a certified diabetes care and education specialist and health coach in Detroit, Michigan,...

02/21/2015

Research Summaries

Research Summary

doctor holding electrocardiogram in front of model heart

Research Summary

Tirzepatide Associated With Fewer Cardiorenal Events in Type 2 Diabetes

04/21/2026

Kate Young

In a post hoc analysis of the SURPASS-CVOT randomized clinical trial, researchers found that tirzepatide was associated with fewer cardiorenal events than dulaglutide in high-risk type 2 diabetes.

04/21/2026

Research Summary

Research Summary

Oral Semaglutide Associated With Fewer Heart Failure Events in Type 2 Diabetes

04/17/2026

Kate Young

In SOUL, oral semaglutide was associated with fewer composite heart failure events in patients with type 2 diabetes and baseline heart failure.

04/17/2026

Timeline Snapshot

Timeline Snapshot

Notable FDA Approvals From March 2026

04/16/2026

March 2026 included several FDA drug and biologic approvals across a range of therapeutic areas. This timeline highlights the key alerts our publication covered throughout the month, giving readers a quick,...

04/16/2026

FDA Approval